结合P-糖蛋白与三重乙酸抑制剂分子的P-糖蛋白的冷EM结构
Norie Hamaguchi-Suzuki1, Naruhiko Adachi2, Toshio Moriya3
1Department of Pharmacology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo, Chiba, 260-8670, Japan; Department of Chemistry, Graduate School of Science, Chiba University, 1-33 Yayoi-cho, Inage, Chiba, 263-8522, Japan.
Biochemical and biophysical research communications
|April 5, 2024
概括
研究人员确定了P-glycoprotein (P-gp) 与elacridar结合的高分辨率的冷EM结构. 这揭示了更多的结合部位,有助于开发用于癌症治疗的改进的P-gp抑制剂.
科学领域:
- 结构生物学 结构生物学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- P-glycoprotein (P-gp) 是一种ATP结合的磁带载体,参与多种药物排放,有助于癌症的耐药性.
- 通过将抗癌药物从细胞中驱逐出来,P-gp降低了抗癌药物的疗效.
- 像elacridar这样的抑制剂是为了克服P-gp介导的耐药性而开发的.
研究的目的:
- 为了获得人类P-gp-Fab (UIC2) 复合物的高分辨率冷电子显微镜 (cryo-EM) 结构,由elacridar.
- 为了确定P-gp上的额外的化合物结合点.
- 为了提高对P-gp的化合物识别机制的理解,用于开发新型抑制剂.
主要方法:
- 低温电子显微镜 (cryo-EM) 用于确定P-gp-Fab (UIC2) 复合物的结构.
- 晶体学用于分析elacridar分子与P-gp的结合.
- 结构分析以识别和描述复合结合口袋.
主要成果:
- 由三个elacridar分子结合的人类P-gp-Fab (UIC2) 复合物的2.5 Å分辨率的冷EM结构得到了.
- 更高分辨率的结构揭示了P-gp内部比预期更大的化合物结合空间.
- 三个elacridar分子的结合为P-gp的基质识别提供了新的见解.
结论:
- 高分辨率结构提供了对elacridar与P-gp结合的更详细的了解.
- 鉴定的结合部位对设计更有选择性和更有效的P-gp抑制剂有影响.
- 这项研究促进了克服癌症治疗中的多药耐药性的策略的开发.
相关概念视频
01:28Cryo-electron Microscopy
3.3K
Conventional electron microscopy (EM) involves dehydration, fixation, and staining of biological samples, which distorts the native state of biological molecules and results in several artifacts. Also, the high-energy electron beam damages the sample and makes it difficult to obtain high-resolution images. These issues can be addressed using cryo-EM, which uses frozen samples and gentler electron beams. The technique was developed by Jacques Dubochet, Joachim Frank, and Richard Henderson, for...
3.3K
01:12GPCR Desensitization
6.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.0K